GE Healthcare Technologies Inc
NASDAQ:GEHC

  • LAST PRICE
    77.0100
  • TODAY'S CHANGE (%)
    -0.2300 (-0.2978%)
  • Bid / Lots
    77.0100/ 1
  • Ask / Lots
    77.0400/ 3
  • Open / Previous Close
    77.2000 / 77.2400
  • Day Range
    76.5500
    77.2500
  • 52 Week Range
    62.3500
    94.5000
  • Volume
    859,045

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Advanced Medical Equipment Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
GEHC
GE Healthcare Technologies Inc
35.3B
22.4x
---
PHG
Koninklijke Philips NV
24.8B
-28.6x
---
A
Agilent Technologies Inc
36.8B
29.9x
+9.42%
RMD
Resmed Inc
27.8B
30.0x
+14.08%
EW
Edwards Lifesciences Corp
54.9B
39.6x
+14.85%
VEEV
Veeva Systems Inc
29.3B
52.5x
+17.29%
As of 2024-07-05

Company Information

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

Contact Information

Headquarters
500 West Monroe StreetCHICAGO, IL, United States 60661
Phone
203-360-4369
Fax
302-655-5049

Executives

Chairman of the Board
H. Lawrence Culp
President, Chief Executive Officer, Director
Peter Arduini
Chief Financial Officer, Vice President
James Saccaro
Chief Executive Officer - Imaging
Jan Makela
Chief Executive Officer - Pharmaceutical Diagnostics
Kevin O'Neill

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$35.3B
Revenue (TTM)
$19.5B
Shares Outstanding
456.5M
Dividend Yield
0.16%
Annual Dividend Rate
0.1200 USD
Ex-Dividend Date
07-19-24
Pay Date
08-15-24
Beta
---
EPS
$3.43
Book Value
$15.67
P/E Ratio
22.4x
Price/Sales (TTM)
1.8
Price/Cash Flow (TTM)
15.9x
Operating Margin
12.39%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.